SCT Associated studies

Open trials

Short name TARGET study
Study title Individualized dosing of fludarabine during innate allo SCT: A randomized phase II study
Status Open
Participants NL-LUMC
DE-Mainz
Study docs Flow + eligibility
Protocol

 

Short name CMV pp65 specific T-cells
Study title Treatment with CMV pp65‐specific T cells generated by use of a CMV pp65 protein‐spanning peptide pool in patients with CMV reactivation or CMV disease after allogeneic stem cell transplantation (alloSCT)
Status Open (only hospital exemptions allowed)
Participants LUMC
Study docs Flow + eligibility
Protocol

 

Short name HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation
Study title A Dose-Escalation, Open Label Phase I Study to Assess the Safety, Feasibility and Preliminary Efficacy of HA-1H TCR Modified T Cells, MDG1021, in Patients With Relapsed or Persistent Hematologic Malignancies After Allogeneic HSCT With or Without Unmanipulated DLI
Reference NCT04464889
Status Open
Participants LUMC

 

Short name TRACE
Study title Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and AdV: A phase III, prospective, multicentre clinical trial
Reference Clinical trials register
Status Open
Participants LUMC

 

 

Up